Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren's syndrome

Rheumatology International

Volumn 28, Issue 2, 2007, Pages 175-177

  Sève, Pascal ^a,b   Gachon, Emilie ^a,b   Petiot, Philippe ^c   Stankovic, Katia ^a,b   Charhon, Annick ^a,b   Broussolle, Christiane ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

Mental nerve neuropathy; Numb chin syndrome; Rituximab; Sj gren's syndrome

Indexed keywords

PREDNISOLONE; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; AGED; ARTHRALGIA; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; NEUROPATHY; NUMB CHIN SYNDROME; OXYGEN THERAPY; PRIORITY JOURNAL; SENSORY NEUROPATHY; SJOEGREN SYNDROME;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MANDIBULAR NERVE; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION DISORDERS; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 36148943910     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0396-4     Document Type: Article

References (14)

1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554-558
2. Bell C (1829): On the nerves of the face: being a second paper on that subject. Philos Trans R Soc Lond 119:317-330
3. Roger H, Paillas J (1937) Le signe du mentonnier (paresthésie et anesthésie unilatérale) révélateur d'un processus néoplasique. Rev Neurol 2:751-752
4. Sweet JM (2004) The numb chin syndrome: a critical sign for primary care physicians. Arch Intern Med 164:1347-1348
5. Abilleira S, Bowler JV (2005) The numb chin syndrome as an early manifestation of giant-cell (temporal) arteritis: a case report. Headache 45:1411-1413
6. Ashworth B, Tait GB (1971) Trigeminal neuropathy in connective tissue disease. Neurology 21:609-614
7. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280-291
8. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G (2005) The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 128:2518-2534
9. Isenberg D (2006) B cell targeted therapies in autoimmune diseases. J Rheumatol Suppl 77:24-28
10. Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H (2005) Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study. Arthritis Rheum 52:2740-2750
11. Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, Candon S, Leguern V, Aouba A, Jean S, Gottenberg JE, Mariette X (2007) Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome. Ann Rheum Dis 66:351-357
12. Ahmadi-Simab K, Lamprecht P, Nolle B, Ai M, Gross WL (2005) Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab. Ann Rheum Dis 64:1087-1088
13. Ring T, Kallenbach M, Praetorius J, Nielsen S, Melgaard B (2006) Successful treatment of a patient with primary Sjogren's syndrome with Rituximab. Clin Rheumatol 25:891-894
14. Gorson KC, Natarajan N, Ropper AH, Weinstein R (2006) Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 35:66-69